AKT1 and neoplasm: Two proven key signaling pathways related to tumor progression and chemotherapy resistance, the phosphatidylinositol 3-kinase (PI3K)-AKT serine/threonine kinase 1 (AKT1) and transforming growth factor β1 pathways (38–40), were also significantly enriched in our study.